Award
Award W81K0026FA048 — EXACT SCIENCES CORPORATION
- Awarded to
- EXACT SCIENCES CORPORATION
- Agency
- Department of Defense
- Estimated value
- $51,809
ONCOTYPE DX BREAST CANCER SCREENING AT WBAMC. FIFTEEN (15) TESTS PER PERIOD OF PERFORMANCE, WITH ONE (1) BASE YEAR AND FOUR (4) OPTION YEARS, FOR A TOTAL OF SEVENTY-FIVE (75) TESTS.
Key dates
- Award date
- February 1, 2026
- Performance start
- February 1, 2026
- Performance end
- January 31, 2027
Who is this buyer
Organization
Buying history
- Records228 total
- Opportunities / awards3 / 194
- Value range$0 – $33,407,783
- ActiveJuly 24, 2026 – October 27, 2026
What they buy
- Clinical (218)
- Administrative (10)
Set-asides used
- No Set aside used (15)
- Small Business Set Aside - Total (6)
Who holds their work today
- DILLIGAS CORP10 wins · $50,648,524 · last January 1, 2026
- GIACARE & MEDTRUST JV LLC6 wins · $44,883,965 · last July 1, 2026
- CENTRALCARE, INCORPORATED7 wins · $34,923,023 · last October 1, 2025
- LABORATORY CORPORATION OF AMERICA23 wins · $33,144,817 · last July 1, 2026
- HOOLAULIMA GOVERNMENT SOLUTIONS, LLC1 win · $25,526,156 · last April 1, 2021
Also open from this buyer
- Human Cadaver - Based Medical Training and Program Support Services for the 44th Medical Brigade stationed at Fort Bragg Army Base, North Carolina.Due October 30, 2026 · Clinical
- Human Cadaver - Based Medical Training and Program Support Services for the 44th Medical Brigade stationed at Fort Bragg Army Base, North Carolina.Due October 30, 2026 · Clinical
- Athletic Trainer (AT) Support personal services - EuropeDue October 6, 2027 · Clinical
View source document →
Source link on usaspending.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 621511
- PSC
- Q301